Scotland backs diabetes drug

People in Scotland with type-2 diabetes now have access to a wider choice of treatments after saxagliptin (Onglyza) was accepted for use within NHS Scotland.

The Scottish Medicine Consortium approved restricted use of the drug in adult patients with type-2 diabetes as an add-on combination therapy with metformin, when metformin plus exercise does not achieve adequate glycaemic control.

The dipeptidyl peptidase4 inhibitor is restricted to use when the addition of sulphonylureas is not deemed to be appropriate.

Its use represents an alternative to other agents such as thiazolidinediones, the SMC said in a statement.

However, the SMC said it could not recommend the use of saxagliptin in combination with sulphonylureas or thiazolidinediones.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

What medico-legal challenges will GPs face in 2019?

What medico-legal challenges will GPs face in 2019?

The MDU's head of advisory services, Dr Caroline Fryar, predicts which medico-legal...

GP practices providing online consultations doubled in 12 months, survey suggests

GP practices providing online consultations doubled in 12 months, survey suggests

The proportion of GP practices in England providing online consultations has almost...

Dr Nikita Kanani: Why peer support is the key to building a stronger general practice

Dr Nikita Kanani: Why peer support is the key to building a stronger general practice

NHS England's acting director of primary care Dr Nikita Kanani says connecting with...

Next-day GP appointments three times as likely to be missed as same-day bookings

Next-day GP appointments three times as likely to be missed as same-day bookings

Patients are nearly three times as likely to miss appointments booked with GP practices...

Outsourcing GP services overseas could be 'legal minefield', experts warn

Outsourcing GP services overseas could be 'legal minefield', experts warn

Using digital technology to outsource GP consultations overseas could leave the NHS...

RCGP sets out advice for GPs on prescribing cannabis

RCGP sets out advice for GPs on prescribing cannabis

GPs should warn patients hoping to access cannabis-based medicines that the process...